NASDAQ:ADTX Aditxt Q2 2025 Earnings Report $0.0032 0.00 (-5.88%) As of 10/2/2026 03:58 PM Eastern ProfileEarnings HistoryForecast Aditxt EPS ResultsActual EPS-$84,207.60Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AAditxt Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AAditxt Announcement DetailsQuarterQ2 2025Date8/14/2025TimeAfter Market ClosesConference Call DateN/AConference Call TimeN/AUpcoming EarningsAditxt's next earnings date is estimated for Wednesday, December 2, 2026, based on past reporting schedules. Conference Call ResourcesEarnings HistoryCompany Profile Aditxt Earnings HeadlinesMerck & Co., Inc. (NYSE:MRK) vs. Aditxt (NASDAQ:ADTX) Head to Head AnalysisOctober 2 at 3:59 AM | americanbankingnews.comAditxt Faces Nasdaq Delisting, Moves Fully to OTCSeptember 23, 2026 | tipranks.comThe case for $20,000 gold before year endPresident Trump reposted a warning from precious metals expert Jim Rickards, tying the November midterms and America's $40 trillion national debt to a potential surge in gold prices, with some forecasts pointing to $10,000 or even $20,000 gold. Dr. David Eifrig, a 40-year market veteran and former Goldman Sachs Vice President, says an unusual plan involving Trump and two other top officials could fuel the biggest gold bull run in decades. Eifrig has shared his top gold pick tied to this developing story.October 4 at 1:00 AM | Stansberry Research (Ad)Aditxt Divests Pearsanta Stake, Retains Royalty UpsideAugust 19, 2026 | tipranks.comAditxt Stock Dividends | NASDAQ:ADTX | BenzingaJuly 13, 2026 | benzinga.comADTX Stock Loses Nasdaq Listing After Seven Reverse Splits Fail To Restore Compliance: Why Is Retail Still Bullish?June 25, 2026 | finance.yahoo.comSee More Aditxt Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Aditxt? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Aditxt and other key companies, straight to your email. Email Address About AditxtAditxt (NASDAQ:ADTX) is a biotechnology company focused on technologies designed to monitor and reprogram the immune system. The company’s work is aimed at supporting precision medicine by providing detailed information about how an individual’s immune system responds to diseases, vaccines and other biological stimuli. Aditxt’s core technology platform, AditxtScore, is designed to analyze multiple immune responses simultaneously. Potential applications include infectious disease testing, vaccine-response monitoring, autoimmune disease research and other areas where immune-system profiling may support diagnosis, treatment development or clinical decision-making. Founded in 2017, Aditxt is headquartered in Mountain View, California. The company has also pursued additional life-sciences initiatives and collaborations intended to expand the use of immune-monitoring and diagnostic technologies. Amro Albanna, a co-founder of the company, has served as its chief executive officer.View Aditxt ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 09/28 - 10/02Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam?Time to Nibble on MCD Stock After it Enters Oversold Territory?Liberty Energy’s AI Power Push Has Wall Street DividedMcCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal UpsideMicron’s Earnings Reveal Why the AI Memory Boom May Last LongerAnthropic's IPO Could Put Amazon's and Alphabet's Paper Profits to the Test Upcoming Earnings PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
